Halberd Company Description

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases.

It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases.

The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Halberd Corporation

Country	United States
Founded	2009
Industry	Biotechnology
Sector	Healthcare
Employees	3
CEO	William Hartman

Contact Details

Address: PO Box 25 Jackson Center, Colorado 16133 United States
Phone	814 786 8849
Website	halberdcorporation.com

Stock Details

Ticker Symbol	HALB
Exchange	OTCMKTS
Fiscal Year	August - July
Reporting Currency	USD
ISIN Number	US4053311092
SIC Code	2834

Key Executives

Name	Position
William A. Hartman	President, Chief Executive Officer and Chairman
John S. Borza AVS, MBA, PE	Chief Operating Officer and Director
Heidi H. Carl	Director and Accounting Director
Dr. Mitchell S. Felder M.D.	Chief Technology Officer and Member of the Scientific Advisory Board
Dr. Patricio F. Reyes FAAN, M.D.	Chief Mechanical Officer and Member of the Scientific Advisory Board